Trim XOM 35-40% into $165-170; hard stop $150, tiered re-entry at $158-160 and $153-156
The 35-40% trim is the empirical center of mass—large enough to convert the five converging bearish signals (MACD momentum divergence, 21.4x P/E valuation premium for below-average growth, unsustainable $10.79 forward EPS consensus, exhausted institutional sentiment, and asymmetric binary event window) into actionable alpha, yet small enough to preserve the structural floor (0.175 trailing beta stabilizer, 41-year dividend streak, $20.67B TTM FCF covering $17B dividend with $3.67B cushion, 0.47x net debt/EBITDA, and $20.5B buyback) that has repeatedly defended against absolute downside; tiered re-entry with explicit technical confirmations (RSI >45, MACD histogram flattening) gives two bites at the apple rather than a single binary trigger that may never fire if oil keeps running or Papua LNG catalyzes a gap higher.
| Position | Action |
|---|---|
| Remaining core position | Size to no more than 1.0x ATR ($3.58) of risk from entry to stop |
| Tail risk hedge | Put overlay sized to 1-2% of portfolio NAV at $155 strike, 60-90 days out |
| Prior Underweight history | 35-40% trim range established as empirical sweet spot from 9/4 (+1.3% alpha), 9/8 (+2.7% alpha), and 9/9 (+1.2% alpha) iterations |
| Neutral analyst framework | 30-50% trim range preferred over Aggressive 60-70% near-exit and Conservative Hold |
XOM is a defensive cash-flow compounder with a near-term operational catalyst, a fortress balance sheet, and a coiled technical setup near all-time highs — getting cheaper on a forward-earnings basis every quarter the company executes.
| Indicator | Value | Signal |
|---|---|---|
| 50 SMA | $153.96 | bullish |
| 200 SMA | $143.79 | bullish |
| 10 EMA | $162.29 | bullish |
| RSI | 60.85 | neutral |
| MACD Line | +2.26 | bullish |
| MACD Histogram | −0.20 | bearish |
| Bollinger Middle (20 SMA) | $161.86 | neutral |
| Bollinger Upper Band | $168.19 | neutral |
| Bollinger Lower Band | $155.53 | neutral |
| ATR | $3.58 | neutral |
| Close (2026-09-10) |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Price tests 50 SMA ($153) AND RSI holds above 45 AND MACD histogram flattens
Then: Deploy second tranche in $153-156 zone with confirmation
Q2 2026 earnings inflection is a structural regime change, not a noise print — one quarter generated 75% of FY2025 full-year FCF
↩ rebuts: “Bear's 'premium valuation' argument using irrelevant trailing P/E”
EV: +5.7% · concedes: Higher rates can compress equity multiples broadly (second derivative); Only 36% probability of another country leaving OPEC (moderate concern); Recession scenario would require 7% priced probability; Only ~4% upside to $172-$175 from current $165 on breakout (modest near-term target)
XOM has printed its cyclical peak quarter (Q2 2026 at $14.5B net income) at a premium valuation (21.4x TTM P/E, 1.41 PEG, highest multiple in peer set) with deteriorating technicals (MACD bearish divergence, failed $168 breakouts) and heavy institutional distribution—making the risk/reward asymmetric to the downside over a 1-2 month tactical horizon.
EV: ~13% drawdown from $165 to $144 (200 SMA retest) · concedes: Q2 2026 was a strong quarter; Balance sheet (0.47x net leverage) is impressive relative to peers; Pioneer synergies are real (though already priced in); Permian Basin is the bull's strongest operational argument; 50% of bull's 'zero cuts bullish for XOM yield' argument (but Fed hike risk outweighs); Dividend streak has resumed
→ vs conservative: The 'add on pullback to 158-161' plan has no mechanism to distinguish bottom from start of 15% waterfall to 144 zone — that's hope, not risk management
→ vs conservative: Conservative flags macro as a risk in their own report but then recommends hold anyway — internal contradiction
→ vs conservative: Waiting for pullback assumes it stops at 158-161; ATR compression suggests it won't be an orderly dip
→ vs neutral: 'Trim into failed breakouts' while simultaneously saying hold is cognitive dissonance — can't run the trade both ways
→ vs neutral: 'Wait for confirmation that Q2 is a new baseline' means waiting to find out if you bought the top — not a strategy, just hope
→ vs neutral: Zero Reddit chatter on XOM is presented as neutral but actually signals institutional saturation and distribution, not retail neutrality
→ vs neutral: All 17 positive headlines in a 7-day window represents the top of the news cycle, not the bottom — classic distribution pattern
→ vs neutral: 17 of 20 positive Dividend Aristocrat headlines is institutional distribution marketing, not accumulation signal
| $165.23 |
| neutral |
Support: 162.29 · 161.86 · 153.96 · 143.79 · 134 | Resistance: 168.98 · 168.19 · 167.37 · 166.15
Net rating is HOLD with a cautiously bullish bias above $161.86; the primary add trigger is a close ≤ $162.20 with RSI ≥ 55 and MACD histogram turning positive, while the trim/exit trigger is a close ≥ $168 with RSI divergence or volume < 13M on breakout; hard stop is a daily close below $158, with risk per trade sized to ≤1.5× ATR ($5.37) from entry to stop.
Market Cap
$682.5 B
Stock Price
~$166
52-Week High
$176.41
52-Week Low
$110.39
50-Day MA
$154.58
200-Day MA
$145.42
Beta
0.175
Trailing P/E
21.36x
Forward P/E
15.38x
PEG Ratio
1.41
Price/Book
2.63x
Dividend Yield
2.51%
EPS (TTM)
$7.77
Forward EPS
$10.79
Revenue FY2022
$398.7 B
Revenue FY2023
$334.7 B
Revenue FY2024
$339.2 B
Revenue FY2025
$323.9 B
Gross Profit FY2022
$103.1 B
Gross Profit FY2023
$84.1 B
Gross Profit FY2024
$76.7 B
Gross Profit FY2025
$71.2 B
EBITDA FY2022
$102.6 B
EBITDA FY2023
$74.3 B
EBITDA FY2024
$73.3 B
EBITDA FY2025
$67.9 B
Net Income FY2022
$55.7 B
Net Income FY2023
$36.0 B
Net Income FY2024
$33.7 B
Net Income FY2025
$28.8 B
Diluted EPS FY2022
$13.26
Diluted EPS FY2023
$8.89
Diluted EPS FY2024
$7.84
Diluted EPS FY2025
$6.70
Revenue Q1 2026
$83.2 B
Revenue Q2 2025
$79.5 B
Revenue Q2 2026
$114.5 B
Net Income Q1 2026
$4.2 B
Net Income Q2 2025
$7.1 B
Net Income Q2 2026
$14.5 B
EPS Q1 2026
$1.00
EPS Q2 2025
$1.64
EPS Q2 2026
$3.48
Gross Margin
29.8%
Operating Margin
15.9%
Net Margin
9.07%
ROE
12.58%
ROA
5.52%
Current Ratio
1.14
Total Assets Q2 2026
$464.5 B
Total Equity Q2 2026
$259.4 B
Total Debt Q2 2026
$42.4 B
Net Debt Q2 2026
$31.8 B
Cash & Equivalents Q2 2026
$10.6 B
Long-Term Debt Q2 2026
$32.2 B
Current Debt Q2 2026
$10.1 B
Working Capital Q2 2026
$12.0 B
Shares Outstanding Q2 2026
4.112 B
Net Debt/EBITDA
~0.47x
Operating Cash Flow FY2025
$52.0 B
CapEx FY2025
$28.4 B
Free Cash Flow FY2025
$23.6 B
Dividends Paid FY2025
$17.2 B
Share Buybacks FY2025
$20.3 B
Operating Cash Flow Q2 2026
$23.6 B
FCF Q2 2026
$17.0 B
CapEx Q2 2026
$6.5 B
Revenue (TTM)
$361.1 B
Gross Profit (TTM)
$107.5 B
EBITDA (TTM)
$67.9 B
Net Income (TTM)
$32.8 B
Debt to Equity
~16%
Strengths
Concerns
ExxonMobil reported a major Q2 2026 inflection with net income surging 105% YoY to $14.5B on volume-driven growth, validating the 15.4x forward P/E, though FY2025 earnings of $28.8B remained the weakest in four years. The balance sheet remains pristine at 0.47x net debt/EBITDA with aggressive buybacks reducing share count by 5.5% since 2024, supporting the HOLD rating pending confirmation that Q2 2026 represents a new earnings baseline rather than a cyclical peak.